This is a freaking bonanza people.
Fast forward just a little.
We do not need to partner with big pharma in the US.
Our strategic investor just happens to have 2200 surgeons, 210,000 patients annually and 200 centres across the states. Plus they are currently opening 15 more centres per year.
Would you think there may be a symbiotic relationship underway besides straight equity?
We provide the cells, no royalty share with anyone, distribution centres in place.
If your back is stuffed there is only one place to go for pain free treatment.
We don't even need a sales force. Surgcentre will handle all that.
Anyone care to project profits on USA back market without having to share royalties???!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
Reg
Ann: Mesoblast Raises US$110M Led By US Strategic Investor Group, page-126
-
- There are more pages in this discussion • 383 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.25 |
Change
-0.053(4.02%) |
Mkt cap ! $1.432B | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.30 | $1.17 | $16.36M | 13.25M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 35677 | $1.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.26 | 44262 | 14 |
View Market Depth
| Last trade - 14.03pm 24/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |